Application of biomarker in colorectal cancer

• Main Authors: HE WENTING, ZHANG HONGLIANG, ZENG FANYE, CHI JIEJUN, FU XIAOLE, JIE YANGHUA, ZHU YANHUA, YANG XIAOBEI, ZHOU YUKUN
• Format: Patent
• Language: Chinese; English
• Published: 05.09.2017
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PHYSICS; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPIRITS; TESTING; VINEGAR; WINE

The invention discloses an application of a biomarker in colorectal cancer. The biomarker is NHEG1 concretely. The expression down-regulation of the NHEG1 in spleen qi deficiency type advanced colorectal cancer patients is found for the first time, so the expression level of the NHEG1 becomes the ba...